EUVIMED · CrossrefJournal
International Journal of Diabetes and Technology
ISSN 2949-8457 · Ovid Technologies (Wolters Kluwer Health)
Latest articles
Healthcare Professionals’ Preferences for Color-coded and Designed Medication Packaging in Type 2 Diabetes Management
Remission of Type 2 Diabetes in India: Insights from a Clinical Case Series
Clinical Impact of Continuous Glucose Monitoring for 6–12 Months in Individuals with Type 2 Diabetes – A Retrospective, Chart-review Study from India
Assessment of Continuous Glucose Monitoring Knowledge in a Type 1 Diabetes Population: An Empower T1D Pre-/Posteducational Intervention Study
Domain-based Basal and Daytime Ambulatory Glycemic Exposure Metrics Derived from Continuous Glucose Monitoring: A Real-world Clinic-based Study
Maternal Diabetic Cardiomyopathy and Fetal Consequences: Reframing Pregnancy with Diabetes as a Maternal–Placental–Fetal Cardiovascular Syndrome Integrating Myocardial Strain, Continuous Glucose Monitoring, and Placental–Fetal Perfusion
Expert Opinion on the Role of Dapagliflozin–Glimepiride–Metformin ER Triple Fixed-dose Combination in Type 2 Diabetes Management: A Pan-India Clinicians’ Survey
Counseling before Diwali, Holi, and Navratri: A Missing Routine in Indian Diabetes Care
A Cross-sectional Study to Assess the Prevalence of Diabetic Peripheral Neuropathy Using Michigan Neuropathy Screening Instrument among Indian Patients with Diabetes
The Most Powerful Diabetes Technology May Still Be Education
Fibrinogen as a Prognostic Biomarker in Patients with Type 2 Diabetes with Coronary Artery Disease: A Propensity-matched Study
DIAOBECON ABSTRACTS 2026
A Phase III, Randomized, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of a Fixed Dose Combination of Dapagliflozin and Pioglitazone in Type 2 Diabetes Mellitus Patients Inadequately Controlled on Metformin Monotherapy
The NEUROSARC-EG Study: Prevalence and Clinical Correlates of Sarcopenia in Egyptian Patients with Type 2 Diabetes and Diabetic Neuropathy – A Cross-sectional Epidemiological Study
Clinician Insights on Telmisartan - Dapagliflozin Combination Therapy for Cardio-renal-metabolic Risk Management: SYNERGY Survey
Mobile Health Applications for Type 2 Diabetes Remission and Weight Management: A Position Statement on Efficacy, Regulation, and Ethical Implementation
Should Dengue Vaccination be Prioritized in Individuals with Diabetes?
Operationalizing Artificial Intelligence-enabled Lifestyle Interventions for Type 2 Diabetes at Scale: A National Strategy for India
A Two-open-label, Prospective, Multicentric, Phase IV Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Imeglimin Hydrochloride Tablets 500 mg and 1000 mg in Individuals with Type 2 Diabetes Mellitus Inadequately Controlled with Diet and Exercise Alone
Modulatory Effects of Rutin on CREM Expression and Testicular Histomorphology in Streptozotocin-Induced Type 2 Diabetic Wistar Rats
Cardio-Kidney-Metabolic Syndrome and Role of Oral Semaglutide
14th JPEF ABSTRACTS 2026
Better the Time in Range, Longer the Time in Life
When Pain Cannot Warn: Catastrophic Fournier’s Gangrene in a Patient with Perineal Neuropathy on Canagliflozin
Optimizing the Use of Continuous Glucose Monitoring in People with Type 2 Diabetes on Noninsulin-based Regimens: A Case Series with Narrative Review and Expert Opinion
Intermittent Use of Flash Glucose Monitoring as a Useful Tool for Patients with Type 1 Diabetes in Developing Countries
Ethical and Legal Implications for the Use of Artificial Intelligence and Telemedicine in Healthcare in India: The Past, Present, and Future Directions
Expert Opinion on Managing Uncontrolled Type 2 Diabetes, with a Special Emphasis on the Use of Dapagliflozin-based Fixed Dose Combinations in the Indian Clinical Settings
Role of Quantum Computing Influencing Artificial Intelligence in Healthcare
EUVIMED